Current treatment for thrombotic diseases.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects; D002986:Clinical Trials as Topic; D000242:Cyclic AMP / Q000096:biosynthesis; D004837:Epinephrine / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D013917:Thrombin / Q000037:antagonists & inhibitors; D013927:Thrombosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D001095:Arachidonic Acids; D005343:Fibrinolytic Agents; D014812:Vitamin K; D016718:Arachidonic Acid; D000244:Adenosine Diphosphate; D006493:Heparin; D000242:Cyclic AMP; D013917:Thrombin; D004837:Epinephrine